ArticleClinical drug investigation2017

Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens.

Amy Puenpatom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.